Revive Therapeutics Ltd. (RVVTF)

 

 
Other OTC - Other OTC Delayed Price. 
0.3274+0.0774 (+30.96%)
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19